Evolutionary consequences of cryptic genetic variation

Phenotypic evolution depends on heritable variation in phenotypes. A central aim of evolutionary biology, therefore, is to understand how processes generating phenotypic variation interact with selection and drift to result in phenotypic evolution. Recent studies have highlighted the propensity for populations to harbor genetic variation that contributes to phenotypic variation only after some environmental or genetic change. Many authors have suggested that release of this cryptic genetic variation by stressful or novel environments can facilitate phenotypic adaptation. However, there is little empirical evidence that stressful or novel environments release cryptic genetic variation, or that, once released, it contributes to phenotypic evolution. We argue that empirical studies are needed to answer these questions, and identify the empirical approaches needed to study the relationship between environment, released cryptic genetic variation and phenotypic evolution

Development of a core outcome set for congenital pulmonary airway malformations: study protocol of an international Delphi survey

Introduction A worldwide lack of consensus exists on the optimal management of asymptomatic congenital pulmonary airway malformation (CPAM) even though the incidence is increasing. Either a surgical resection is performed or a wait-and-see policy is employed, depending on the treating physician. Management is largely based on expert opinion and scientific evidence is scarce. Wide variations in outcome measures are seen between studies making comparison difficult thus highlighting the lack of universal consensus in outcome measures as well. We aim to define a core outcome set which will include the most important core outcome parameters for paediatric patients with an asymptomatic CPAM.Methods and analysis This study will include a critical appraisal of the current literature followed by a three-stage Delphi process with two stakeholder groups. One surgical group including paediatric as well as thoracic surgeons, and a non-surgeon group including paediatric pulmonologists, intensive care and neonatal specialists. All participants will score outcome parameters according to their level of importance and the most important parameters will be determined by consensus.Ethics and dissemination Electronic informed consent will be obtained from all participants. Ethical approval is not required. After the core outcome set has been defined, we intend to design an international randomised controlled trial: the COllaborative Neonatal NEtwork for the first CPAM Trial, which will be aimed at determining the optimal management of patients with asymptomatic CPAM

Low‐temperature tolerance in coprophagic beetle species (Coleoptera: Scarabaeidae): implications for ecological services

1. Low temperatures affect insect functioning and population dynamics. Although temperate species cope with low temperatures better than their tropical counterparts, increasing temperature variability due to climate change exposes tropical species to frequent cold stress. For keystone insect species providing important ecosystem services, low-temperature tolerances, and behavioural responses remain unknown, hampering predictions under climate change. 2. The present study examined low-temperature physiology [critical thermal minima (CTmin) and chill coma recovery time (CCRT)] of six dung beetle species across three activity times: diurnal Allogymnopleurus indigaceous (Reiche) and Euoniticellus intermedius (Reiche); crepuscular Onthophagus alexis (Klug) and Onthophagus gazella (Fabricius), and; nocturnal Copris elephenor (Klug) and Scarabaeus zambezianus (Peringuey). Further, ecological service delivery (dung removal) was examined between diurnal and nocturnal species across the temperature regimes. 3. Nocturnal species had significantly greater cold tolerance than both crepuscular and diurnal species, while CCRT was significantly shortest in diurnal than both crepuscular and nocturnal species. Dung ball production between diurnal and nocturnal species interacted with temperature, with diurnal species producing significantly fewer balls at low temperatures, while nocturnal beetles were not significantly affected. In turn, nocturnal species produced significantly larger balls than the diurnal species across temperatures. Effects of temperature regime shifts were intertwined with the foraging ecology of individual species. 4. Future research should quantify species' functional responses toward different amounts of dung masses as stressful temperatures increase. 5. Results are significant for determination of species thermal ranges and predicting costs of low-temperature stress through reduced ecological services under shifting thermal environments

Fermi-GBM Discovery of GRB 221009A: An Extraordinarily Bright GRB from Onset to Afterglow

International audienceWe report the discovery of GRB 221009A, the highest flux gamma-ray burst ever observed by the Fermi Gamma-ray Burst Monitor (GBM). This GRB has continuous prompt emission lasting more than 600 seconds, afterglow visible in the \gbm energy range (8 keV--40 MeV), and total energetics higher than any other burst in the GBM sample. By using a variety of new and existing analysis techniques we probe the spectral and temporal evolution of GRB 221009A. We find no emission prior to the GBM trigger time (t0; 2022 October 9 at 13:16:59.99 UTC), indicating that this is the time of prompt emission onset. The triggering pulse exhibits distinct spectral and temporal properties suggestive of shock-breakout with significant emission up to $\sim$15 MeV. We characterize the onset of external shock at \t0+600 s and find evidence of a plateau region in the early-afterglow phase which transitions to a slope consistent with \swift-XRT afterglow measurements. We place the total energetics of GRB 221009A in context with the rest of the GBM sample and find that this GRB has the highest total isotropic-equivalent energy ($\textrm{E}_{\gamma,\textrm{iso}}=1.0\times10^{55}$ erg) and second highest isotropic-equivalent luminosity ($\textrm{L}_{\gamma,\textrm{iso}}=9.9\times10^{53}$ erg/s) based on redshift of z = 0.151. These extreme energetics are what allowed GBMto observe the continuously emitting central engine from the beginning of the prompt emission phase through the onset of early afterglow

Fermi-GBM Discovery of GRB 221009A: An Extraordinarily Bright GRB from Onset to Afterglow

International audienceWe report the discovery of GRB 221009A, the highest flux gamma-ray burst ever observed by the Fermi Gamma-ray Burst Monitor (GBM). This GRB has continuous prompt emission lasting more than 600 seconds, afterglow visible in the \gbm energy range (8 keV--40 MeV), and total energetics higher than any other burst in the GBM sample. By using a variety of new and existing analysis techniques we probe the spectral and temporal evolution of GRB 221009A. We find no emission prior to the GBM trigger time (t0; 2022 October 9 at 13:16:59.99 UTC), indicating that this is the time of prompt emission onset. The triggering pulse exhibits distinct spectral and temporal properties suggestive of shock-breakout with significant emission up to $\sim$15 MeV. We characterize the onset of external shock at \t0+600 s and find evidence of a plateau region in the early-afterglow phase which transitions to a slope consistent with \swift-XRT afterglow measurements. We place the total energetics of GRB 221009A in context with the rest of the GBM sample and find that this GRB has the highest total isotropic-equivalent energy ($\textrm{E}_{\gamma,\textrm{iso}}=1.0\times10^{55}$ erg) and second highest isotropic-equivalent luminosity ($\textrm{L}_{\gamma,\textrm{iso}}=9.9\times10^{53}$ erg/s) based on redshift of z = 0.151. These extreme energetics are what allowed GBMto observe the continuously emitting central engine from the beginning of the prompt emission phase through the onset of early afterglow

Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery

Background: Ileus is common after elective colorectal surgery, and is associated with increased adverse events and prolonged hospital stay. The aim was to assess the role of non-steroidal anti-inflammatory drugs (NSAIDs) for reducing ileus after surgery. Methods: A prospective multicentre cohort study was delivered by an international, student- and trainee-led collaborative group. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The primary outcome was time to gastrointestinal recovery, measured using a composite measure of bowel function and tolerance to oral intake. The impact of NSAIDs was explored using Cox regression analyses, including the results of a centre-specific survey of compliance to enhanced recovery principles. Secondary safety outcomes included anastomotic leak rate and acute kidney injury. Results: A total of 4164 patients were included, with a median age of 68 (i.q.r. 57\u201375) years (54\ub79 per cent men). Some 1153 (27\ub77 per cent) received NSAIDs on postoperative days 1\u20133, of whom 1061 (92\ub70 per cent) received non-selective cyclo-oxygenase inhibitors. After adjustment for baseline differences, the mean time to gastrointestinal recovery did not differ significantly between patients who received NSAIDs and those who did not (4\ub76 versus 4\ub78 days; hazard ratio 1\ub704, 95 per cent c.i. 0\ub796 to 1\ub712; P = 0\ub7360). There were no significant differences in anastomotic leak rate (5\ub74 versus 4\ub76 per cent; P = 0\ub7349) or acute kidney injury (14\ub73 versus 13\ub78 per cent; P = 0\ub7666) between the groups. Significantly fewer patients receiving NSAIDs required strong opioid analgesia (35\ub73 versus 56\ub77 per cent; P < 0\ub7001). Conclusion: NSAIDs did not reduce the time for gastrointestinal recovery after colorectal surgery, but they were safe and associated with reduced postoperative opioid requirement